Vitamins D Market Research Report Forecast Till 2030

Vitamins D Market is expected to register a CAGR of 6% during the review period. The key variables driving the, rising demand for normally sourced vitamins in end-use industries are anticipated to set out a freedom for market players working in the vitamins market are a portion of the essential elements adding to its market development.

Vitamin D deficiency significantly causes rickets in children and osteoporosis in adults. It is additionally linked to hypertension, normal malignancies, and viral sicknesses. Additionally, vitamin D is fundamental for the development of skeletal construction and dental veneer in children. It can create various issues in babies, like touchiness, development disappointment, and a higher endanger of respiratory diseases sometime down the road.

The rising commonness and mindfulness regarding the dangers associated with vitamin D deficiency are expected to be a central point driving the development of the global vitamin D market for the gauge period.

Market Segmentation

The global vitamin D market segmentation, based on the type, includes vitamins D3 and vitamins D2.

The global vitamin D market form data has been bifurcated by bakery & confectionery, dairy and frozen desserts, meat alternatives, oils & fats, sports nutrition, dairy alternatives, dietary supplements, breakfast cereals, and others.

Regional Insights

Europe region includes nations like Germany, France, Italy, Spain, the UK, Netherlands, and the Remainder of European nations. Europe represents a 33.01% portion of the global vitamin D market. The region has portrayed gradual development over the verifiable period and is expected to proceed with high development during the estimate. The development in the region can be attributed to the development of the nutraceuticals area, expanding demand for useful food, and the high adoption of elective diets. According to the WHO, roughly 70% of European customers experience the ill effects of vitamin D deficiency. In addition, the rising geriatric populace in Europe, particularly the UK, Germany, and France, is anticipated to push market development. The demand for regular labeled products has been flooding throughout the course of recent years in the EU due to expanding purchaser inclination for natural and normal certified food and enhancements. Germany is the leading nation-level market in the region, representing the biggest market share during the audit period.

The Asia-Pacific vitamins D market is second of the biggest regions in the Vitamins D Market. Asia-Pacific region includes nations like China, Japan, India, Australia and New Zealand, and the Remainder of Asia-Pacific. The region accounted for 28.16% of the market in 2020. The development of the vitamin D market in Asia-Pacific can be attributed to an emphasis on preventive medical care over remedial arrangements. The rising purchaser tendency to adopt sound ways of life is anticipated to move market development in the region.

Major Players

Key Companies in the Vitamins D market include DSM N.V. (Netherlands), BASF SE (Germany), Farbest Brands (US), Zhejiang Garden Biochemical High-tech Co., Ltd. (China), Pharmavit (Netherlands), Prinova Group LLC. (US), Piramal Pharma Solutions (India), SternVitamin GmbH & Co. KG (Germany), Fermenta Biotech Limited (India), and Glanbia plc. (Ireland).

Product Code: MRFR/F-B & N/10454-CR

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 MARKET ATTRACTIVENESS ANALYSIS
- 1.1.1 GLOBAL VITAMINS D MARKET, BY TYPE
- 1.1.2 GLOBAL VITAMINS D MARKET, BY APPLICATION
- 1.1.3 GLOBAL VITAMINS D MARKET, BY REGION

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 KEY BUYING CRITERIA

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
3.6 LIST OF ASSUMPTIONS & LIMITATIONS

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING PREVALENCE OF VITAMINS D DEFICIENCY
- 4.2.2 INCREASING DEMAND FOR VITAMINS D INGREDIENTS IN THE COSMETIC INDUSTRY
- 4.2.3 INCREASING HEALTH CONSCIOUSNESS AMONG THE POPULATION
- 4.2.4 DRIVERS IMPACT ANALYSIS
4.3 RESTRAINT
- 4.3.1 SIDE EFFECTS ASSOCIATED WITH OVERCONSUMPTION OF VITAMINS D
- 4.3.2 RESTRAINT IMPACT ANALYSIS
4.4 OPPORTUNITIES
- 4.4.1 RISING DEMAND FOR NATURALLY SOURCED VITAMINS IN END-USE INDUSTRIES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 RAW MATERIAL PROCUREMENT
- 5.1.2 PROCESSING
- 5.1.3 PACKAGING
5.2 SUPPLY CHAIN ANALYSIS
5.3 PORTER'S FIVE FORCES MODEL
- 5.3.1 THREAT OF NEW ENTRANTS
- 5.3.2 BARGAINING POWER OF SUPPLIERS
- 5.3.3 THREAT OF SUBSTITUTES
- 5.3.4 BARGAINING POWER OF BUYERS
- 5.3.5 RIVALRY
5.4 TECHNOLOGICAL ADVANCEMENT
5.5 CONSUMER BUYING BEHAVIOR
5.6 REGULATORY SCENARIO

6 GLOBAL VITAMINS D MARKET, BY TYPE

6.1 OVERVIEW
- 6.1.1 GLOBAL VITAMINS D MARKET ESTIMATES & FORECAST, BY TYPE, 2015–2031
6.2 VITAMINS D3
- 6.2.1 VITAMINS D3: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031
6.3 VITAMINS D2
- 6.3.1 VITAMINS D2: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031

7 GLOBAL VITAMINS D MARKET, BY APPLICATION

7.1 OVERVIEW
- 7.1.1 GLOBAL VITAMINS D MARKET ESTIMATES & FORECAST, BY APPLICATION, 2015–2031
7.2 BAKERY & CONFECTIONERY
- 7.2.1 BAKERY & CONFECTIONERY: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031
7.3 DAIRY & FROZEN DESSERTS
- 7.3.1 DAIRY & FROZEN DESSERTS: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031
7.4 MEAT ALTERNATIVES
- 7.4.1 MEAT ALTERNATIVES: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031
7.5 OILS & FATS
- 7.5.1 OILS & FATS: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031
7.6 SPORTS NUTRITION
- 7.6.1 SPORTS NUTRITION: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031
7.7 DAIRY ALTERNATIVES
- 7.7.1 DAIRY ALTERNATIVES: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031
7.8 DIETARY SUPPLEMENTS
- 7.8.1 DIETARY SUPPLEMENTS: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031
7.9 BREAKFAST CEREALS
- 7.9.1 BREAKFAST CEREALS: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031
7.10 OTHERS
- 7.10.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2015–2031

8 GLOBAL VITAMINS D MARKET, BY REGION

8.1 OVERVIEW
8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 CANADA
8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 UK
- 8.3.3 FRANCE
- 8.3.4 ITALY
- 8.3.5 SPAIN
- 8.3.6 NETHERLANDS
- 8.3.7 REST OF EUROPE
8.4 ASIA-PACIFIC
- 8.4.1 CHINA
- 8.4.2 JAPAN
- 8.4.3 AUSTRALIA & NEW ZEALAND
- 8.4.4 INDIA
- 8.4.5 REST OF ASIA-PACIFIC
8.5 LATIN AMERICA
- 8.5.1 BRAZIL
- 8.5.2 MEXICO
- 8.5.3 ARGENTINA
- 8.5.4 REST OF LATIN AMERICA
8.6 MIDDLE EAST
- 8.6.1 GCC COUNTRIES
- 8.6.2 IRAN
- 8.6.3 REST OF THE MIDDLE EAST
8.7 AFRICA
- 8.7.1 SOUTH AFRICA
- 8.7.2 EGYPT
- 8.7.3 REST OF AFRICA

9 COMPARISONS OF FORTIFIED VS OVERALL PRODUCTS

9.1 GLOBAL FOOD & BEVERAGES MARKET 2015–2031
9.2 GLOBAL FOOD & BEVERAGES MARKET 2015–2031

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
- 10.1.1 MARKET STRATEGY ANALYSIS
10.2 COMPETITIVE BENCHMARKING
10.3 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.3.1 PRODUCT LAUNCH
- 10.3.2 ACQUISITION
- 10.3.3 EXPANSION
- 10.3.4 COLLABORATION
10.4 COMPANY MARKET SHARE ANALYSIS, 2020
- 10.4.1 MANUFACTURERS OF VITAMINS D
- 10.4.2 CMOS & PREMIX SOLUTION PROVIDERS
- 10.4.3 FORTIFIED FOOD & BEVERAGES MANUFACTURERS

11 COMPANY PROFILES

11.1 KONINKLIJKE DSM N.V.
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 BASF SE
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGIES
11.3 FARBEST BRANDS
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 KEY STRATEGIES
11.4 ZHEJIANG GARDEN BIOCHEMICAL HIGH-TECH CO., LTD
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 KEY STRATEGIES
11.5 PHARMAVIT
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 KEY STRATEGIES
11.6 PRINOVA GROUP LLC
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 KEY STRATEGIES
11.7 PIRAMAL PHARMA SOLUTIONS
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 STERNVITAMIN GMBH & CO. KG
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 KEY STRATEGIES
11.9 FERMENTA BIOTECH LIMITED
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 KEY STRATEGIES
11.10 GLANBIA PLC
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 SWOT ANALYSIS
- 11.10.6 KEY STRATEGIES
11.11 THE COCA-COLA COMPANY
- 11.11.1 COMPANY OVERVIEW
- 11.11.2 FINANCIAL OVERVIEW
- 11.11.3 PRODUCTS OFFERED
- 11.11.4 KEY DEVELOPMENTS
- 11.11.5 SWOT ANALYSIS
- 11.11.6 KEY STRATEGIES
11.12 CREAMLINE DAIRY PRODUCTS LIMITED
- 11.12.1 COMPANY OVERVIEW
- 11.12.2 FINANCIAL OVERVIEW
- 11.12.3 PRODUCTS OFFERED
- 11.12.4 KEY DEVELOPMENTS
- 11.12.5 KEY STRATEGIES
11.13 MOTHER DAIRY
- 11.13.1 COMPANY OVERVIEW
- 11.13.2 FINANCIAL OVERVIEW
- 11.13.3 PRODUCTS OFFERED
- 11.13.4 KEY DEVELOPMENTS
- 11.13.5 KEY STRATEGIES
11.14 PEPSICO, INC.
- 11.14.1 COMPANY OVERVIEW
- 11.14.2 FINANCIAL OVERVIEW
- 11.14.3 PRODUCTS OFFERED
- 11.14.4 KEY DEVELOPMENTS
- 11.14.5 KEY STRATEGIES
11.15 NESTLÉ S.A
- 11.15.1 COMPANY OVERVIEW
- 11.15.2 FINANCIAL OVERVIEW
- 11.15.3 PRODUCTS OFFERED
- 11.15.4 KEY DEVELOPMENTS
- 11.15.5 KEY STRATEGIES
11.16 CHLOROPHYLL WATER
- 11.16.1 COMPANY OVERVIEW
- 11.16.2 FINANCIAL OVERVIEW
- 11.16.3 PRODUCTS OFFERED
- 11.16.4 KEY DEVELOPMENTS
- 11.16.5 KEY STRATEGIES
11.17 THE KELLOGG COMPANY
- 11.17.1 COMPANY OVERVIEW
- 11.17.2 FINANCIAL OVERVIEW
- 11.17.3 PRODUCTS OFFERED
- 11.17.4 KEY DEVELOPMENTS
- 11.17.5 KEY STRATEGIES
11.18 THE HAIN CELESTIAL GROUP, INC
- 11.18.1 COMPANY OVERVIEW
- 11.18.2 FINANCIAL OVERVIEW
- 11.18.3 PRODUCTS OFFERED
- 11.18.4 KEY DEVELOPMENTS
- 11.18.5 KEY STRATEGIES
11.19 GENERAL MILLS, INC
- 11.19.1 COMPANY OVERVIEW
- 11.19.2 FINANCIAL OVERVIEW
- 11.19.3 PRODUCTS OFFERED
- 11.19.4 KEY DEVELOPMENTS
- 11.19.5 KEY STRATEGIES
11.20 DANONE S.A.
- 11.20.1 COMPANY OVERVIEW
- 11.20.2 FINANCIAL OVERVIEW
- 11.20.3 PRODUCTS OFFERED
- 11.20.4 KEY DEVELOPMENTS
- 11.20.5 KEY STRATEGIES

12 REFERENCES